Genenta Science S.p.A. (SAEN) — research page
US · us-cm-kg/NASDAQ/SAEN · as of 2026-11-08
Identity and listing
The issuer is Genenta Science S.p.A., listed on NASDAQ under ticker SAEN. The ISIN is not on the record. The LEI is not on the record. The security type is Non-operating entity type (other). The segment is not on the record. The sector is 2836 Biological Products, (No Diagnostic Substances). The jurisdiction is Italy. The issuer is listed and not halted.
| field | value | source · read date |
|---|---|---|
| name | Genenta Science S.p.A. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | SAEN | source · 2026-11-08 |
| ISIN | not on the record | |
| LEI | not on the record | |
| security type | Non-operating entity type (other) | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2836 Biological Products, (No Diagnostic Substances) | source · 2026-11-08 |
| jurisdiction | Italy | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 40 filings in the window 2025-11-08 to 2026-11-08, across 27 filing days. Of these, 24 are results, 12 are directors' dealings, 3 are regulatory filings and 1 is a prospectus. The median gap between filing days is 7.5 days. The latest filing is dated 2026-11-02, is of type results, and was filed 6 days before the record date of 2026-11-08. On NASDAQ the median cadence gap is 6.0 days, the median filings count is 52, and the median latency is 5.0 days. In the sector 2836 Biological Products, (No Diagnostic Substances) the median cadence gap is 5.5 days, the median filings count is 65.5, and the median latency is 4.0 days.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 40 | 7.5 | 6 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2836 Biological Products, (No Diagnostic Substances) (176 issuers) | 65.5 | 5.5 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-02 | results | 6-K | 6-K — 6-K |
| 2026-10-22 | results | 6-K | 6-K — 6-K |
| 2026-10-21 | results | 6-K | 6-K — 6-K |
| 2026-10-13 | results | 6-K | 6-K — 6-K |
| 2026-10-07 | results | 6-K | 6-K — 6-K |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor is not on the record, because the latest annual report cover carries no auditor name tag. The auditor's location is not on the record. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting, name change or segment move lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because exchange tier transfers are not EDGAR filings. The issuer is listed and not halted.
Orderability
The outcome is not determinable under rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, as of chapter date 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's investor-relations page. The count is 0.
Open research
The record holds one openly published research note: publisher Genenta Science, dated 2020-11-01.
| date | publisher | note | kind |
|---|---|---|---|
| 2020-11-01 | Genenta Science | Temferon™, an ex-vivo genetically modified cell therapy aiming to fill the gaps for solid tumor immunotherapy | issuer-sponsored |
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The vintage is sealed. The record holds no sealed years for this issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.
Sources
7 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://data.sec.gov/submissions/CIK0001838716.json (identity.jurisdiction)
- 10.3
- https://mcp.us-cm-kg.ai/events/NASDAQ/SAEN (the disclosure lines)
- 10.4
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.5
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.6
- https://www.genenta.com/wp-content/uploads/2021/02/2020-11_Mazzoleni-Expert-Insight.pdf (open research)
- 10.7
- https://mcp.us-cm-kg.ai/record/NASDAQ/SAEN (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"ticker":"SAEN","exchange":"NASDAQ"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:c10929d22ba2859d.